Hyponatremia - Complications, Prognosis, Epidemiology in Finnish Tertiary Care
Key facts
- Who runs it
- University of Turku
- Where
- Finland1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 10,000 people enrolled
- Started
- 1 Sept 2023
- Expected to end
- 31 Dec 2028
- Type of study
- Observational
- Record updated
- 24 February 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- Two sodium measurements in Tyks laboratories between 12-36 hours
Who cannot take part
- -
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Study Objectives and Hypothesis
Read full original descriptionShow less
To determine the incidence of hyponatremia at TYKS and the factors associated with it.
To assess how rapidly hyponatremia was corrected and how the rate of correction affected patient prognosis.
To evaluate treatment modalities and their impact on patient prognosis, length of hospital stay, and their appropriateness in comparison with national and international treatment guidelines.
To determine the incidence of osmotic demyelination at TYKS and the factors associated with it.
To assess other complications and their clinical significance.
To evaluate the impact of hyponatremia on various endpoints, such as mortality, length of hospital stay, seizures, confusion, and similar outcomes.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Clinical Significance of Hyponatremia
- Record updated
- 24 February 2026